Bladder Cancer Microarray Analysis (GSE7476)

Comprehensive transcriptomic analysis of bladder cancer using Affymetrix microarray data

Overview

This project presents a comprehensive analysis of the GSE7476 bladder cancer microarray dataset using R and Bioconductor. The analysis investigates gene expression differences across bladder cancer groups relative to controls, identifies shared and group-specific transcriptional changes, and explores the biological pathways associated with these changes.

The workflow integrates differential gene expression analysis, functional enrichment, Gene Set Enrichment Analysis (GSEA), candidate gene prioritization, and sensitivity analyses to provide a broader understanding of the transcriptional landscape of bladder cancer.

Research Objectives

Identify differentially expressed genes (DEGs) across the experimental comparisons.

Investigate shared and group-specific gene expression patterns.

Characterize enriched biological processes and molecular pathways.

Explore pathway-level transcriptional changes using Hallmark GSEA.

Prioritize candidate genes based on differential expression evidence.

Evaluate the robustness of findings through annotation and ranking sensitivity analyses.

Dataset

GEO Accession: GSE7476

Platform: Affymetrix Human Genome U133 Plus 2.0 Array (GPL570)

Technology: Gene expression microarray

Samples: 12

Experimental groups: Four groups, with three samples per group:

Control

TaGL

T1GH

T2-4

The original CEL files are available through the Gene Expression Omnibus (GEO). Raw data files are not included in this repository.

Analytical Workflow

1. Data Acquisition and Quality Control

Import of raw Affymetrix CEL files.

Inspection of raw expression intensity distributions.

Density and boxplot visualization.

Principal Component Analysis (PCA).

Sample-to-sample correlation analysis.

2. Data Normalization

Background correction using the IdealMM approach.

Quantile normalization.

Expression summarization using average log intensity.

Evaluation of normalized expression distributions.

3. Probe Annotation

Annotation using the hgu133plus2.db Bioconductor package.

Mapping of probe identifiers to gene symbols, gene names, and Entrez Gene IDs.

Assessment of annotation ambiguity and multiple probe-to-gene mappings.

4. Differential Gene Expression Analysis

Differential expression analysis using the limma package.

Comparisons:

TaGL vs Control

T1GH vs Control

T2-4 vs Control

Multiple-testing correction using the Benjamini–Hochberg procedure.

Identification and visualization of significant probes and genes.

Significance threshold: Adjusted p-value < 0.05.

5. Overlap and Gene-Level Analysis

Identification of shared and comparison-specific significant probes.

Venn diagram visualization.

Evaluation of expression direction among shared probes.

Gene-level deduplication using the most statistically significant representative probe for each gene.

6. Functional Enrichment Analysis

Functional characterization of significant genes using:

Gene Ontology (GO) Biological Process.

Kyoto Encyclopedia of Genes and Genomes (KEGG).

Reactome Pathway Analysis.

Both individual and comparative enrichment analyses were performed, including separate analyses of upregulated and downregulated genes.

7. Gene Set Enrichment Analysis

Hallmark gene set enrichment analysis.

Ranked gene lists based on differential expression statistics.

Comparison of pathway enrichment patterns across experimental groups.

Assessment of ranking-method sensitivity.

8. Candidate Gene Prioritization

Integration of differential expression and annotation results to identify candidate genes for further investigation.

9. Sensitivity Analysis

Evaluation of ambiguous probe annotations.

Comparison of alternative gene-level annotation strategies.

Assessment of the robustness of significant gene findings.

